These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 23108543)
1. Functional diversity on synaptic plasticity mediated by endocannabinoids. Cachope R Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3242-53. PubMed ID: 23108543 [TBL] [Abstract][Full Text] [Related]
2. Endocannabinoids and synaptic function in the CNS. Hashimotodani Y; Ohno-Shosaku T; Kano M Neuroscientist; 2007 Apr; 13(2):127-37. PubMed ID: 17404373 [TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid signaling and synaptic plasticity in the brain. Zhu PJ Crit Rev Neurobiol; 2006; 18(1-2):113-24. PubMed ID: 17725514 [TBL] [Abstract][Full Text] [Related]
11. Cannabis y los sistemas exocannabinoide y endocannabinoide. Su uso y controversias. Millán-Guerrero RO; Isais-Millán S Gac Med Mex; 2019; 155(5):508-512. PubMed ID: 31695229 [TBL] [Abstract][Full Text] [Related]
12. Why do cannabinoid receptors have more than one endogenous ligand? Di Marzo V; De Petrocellis L Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3216-28. PubMed ID: 23108541 [TBL] [Abstract][Full Text] [Related]
13. Presynaptic nanoscale components of retrograde synaptic signaling. Barti B; Dudok B; Kenesei K; Zöldi M; Miczán V; Balla GY; Zala D; Tasso M; Sagheddu C; Kisfali M; Tóth B; Ledri M; Vizi ES; Melis M; Barna L; Lenkei Z; Soltész I; Katona I Sci Adv; 2024 May; 10(22):eado0077. PubMed ID: 38809980 [TBL] [Abstract][Full Text] [Related]
14. The endocannabinoidome in neuropsychiatry: Opportunities and potential risks. Morris G; Walder K; Kloiber S; Amminger P; Berk M; Bortolasci CC; Maes M; Puri BK; Carvalho AF Pharmacol Res; 2021 Aug; 170():105729. PubMed ID: 34119623 [TBL] [Abstract][Full Text] [Related]
15. Exogenous and endogenous cannabinoids control synaptic transmission in mice nucleus accumbens. Robbe D; Alonso G; Manzoni OJ Ann N Y Acad Sci; 2003 Nov; 1003():212-25. PubMed ID: 14684448 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of endocannabinoid control of synaptic plasticity. Winters BL; Vaughan CW Neuropharmacology; 2021 Oct; 197():108736. PubMed ID: 34343612 [TBL] [Abstract][Full Text] [Related]
17. Modulation of excitatory synaptic transmission by Delta 9-tetrahydrocannabinol switches from agonist to antagonist depending on firing rate. Roloff AM; Thayer SA Mol Pharmacol; 2009 Apr; 75(4):892-900. PubMed ID: 19118122 [TBL] [Abstract][Full Text] [Related]
18. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies. Millán-Guerrero RO; Isais-Millán S Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020 [TBL] [Abstract][Full Text] [Related]
19. Synaptic functions of endocannabinoid signaling in health and disease. Araque A; Castillo PE; Manzoni OJ; Tonini R Neuropharmacology; 2017 Sep; 124():13-24. PubMed ID: 28625718 [TBL] [Abstract][Full Text] [Related]
20. Dietary PUFAs and Exercise Dynamic Actions on Endocannabinoids in Brain: Consequences for Neural Plasticity and Neuroinflammation. Park Y; Watkins BA Adv Nutr; 2022 Oct; 13(5):1989-2001. PubMed ID: 35675221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]